REVENUE AND DEFERRED REVENUE

3 Months Ended

Mar. 31, 2026

Revenue from Contract with Customer [Abstract]

REVENUE AND DEFERRED REVENUE

6. REVENUE AND DEFERRED REVENUE

Total revenue disaggregated by geographic source, type of customer, and products or services was as follows.

	Three Months Ended March 31,
	2026		2025
United States (medical practice, clinic, and hospital customers):
Products (capsules and capsule reading devices)	$	1,749	$	1,916
Services (cloud-based video delivery and reading services)	266		232
Outside United States (distributor customers):
Products (capsules and capsule reading devices)	777		635
Total revenue	$	2,792	$	2,783

For the three months ended March 31, 2026 and 2025, U.S. service revenues included (i) $168 and $147, respectively, from the Company’s cloud-based software-as-a-service video delivery offering (recognized over time commencing with the shipment of capsules) and (ii) $98 and $85, respectively, of revenue from the provision of video reading to customers (recognized at a point in time upon provision of deliverables).

Product revenues outside the United States are attributable to individual foreign countries based upon shipment destination. The Company’s distributor customers outside the United States typically serve the countries in which they are domiciled (and may distribute to adjacent countries or territories). Outside the United States, for the three months ended March 31, 2026, product revenues included $311 and $255 attributable to France and Germany, respectively, with the balance attributable to other countries; for the three months ended March 31, 2025 product revenues included $252 and $160 attributable to France and Germany, respectively, with the balance attributable to other countries.

Deferred revenue (contract liabilities, all of which are current in nature) consists of upfront purchases by customers related to the cloud-based software-as-a-service video delivery offering and prepaid video reading services. Deferred revenue represents the excess of amounts invoiced over amounts recognized as revenues. For each component of deferred revenue, the recognition of deferrals as revenue occurred within three months.

The Company's deferred revenue balance was $84, $177 and $132 as of March 31, 2026, December 31, 2025 and December 31, 2024, respectively. During the three months ended March 31, 2026, the Company recognized $177 of revenue that was included in deferred revenue as of December 31, 2025. During the three months ended March 31, 2025, the Company recognized $132 of revenue that was included in deferred revenue as of December 31, 2024.

Fees paid to group purchasing organizations and recorded as reductions to revenue were $9 and $22 for the three months ended March 31, 2026 and 2025, respectively.